Cargando…

Progressive multifocal fibrosing neuropathy: description of a novel disease

Entrapment peripheral neuropathies are clinically characterized by sensory impairment and motor deficits. They are usually caused by mechanical injuries, but they are also a frequent manifestation of metabolic diseases, toxic agent exposure, or systemic fibrotic disorders. Here we describe the clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendoza, Fabian A., Bagley, Jennifer, Gochfeld, Michael, Dalakas, Marinos C., Farber, John L., Jimenez, Sergio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925190/
https://www.ncbi.nlm.nih.gov/pubmed/35296359
http://dx.doi.org/10.1186/s40478-022-01341-8
_version_ 1784670017083670528
author Mendoza, Fabian A.
Bagley, Jennifer
Gochfeld, Michael
Dalakas, Marinos C.
Farber, John L.
Jimenez, Sergio A.
author_facet Mendoza, Fabian A.
Bagley, Jennifer
Gochfeld, Michael
Dalakas, Marinos C.
Farber, John L.
Jimenez, Sergio A.
author_sort Mendoza, Fabian A.
collection PubMed
description Entrapment peripheral neuropathies are clinically characterized by sensory impairment and motor deficits. They are usually caused by mechanical injuries, but they are also a frequent manifestation of metabolic diseases, toxic agent exposure, or systemic fibrotic disorders. Here we describe the clinical, radiological, and histopathological features of a novel progressive fibrotic disorder characterized by progressive multifocal fibrosing neuropathy. We identified two patients who presented with severe and progressive peripheral neuropathic symptoms sequentially affecting multiple sites. These patients presented with severe and progressive multifocal, sequentially additive peripheral neuropathic symptoms. Extensive nerve conduction and radiological studies showed the sequential development of multifocal motor and sensory peripheral neuropathy in the absence of any exposure to known infectious, inflammatory, or fibrotic triggers and the lack of family history of compression neuropathies. Extensive clinical and laboratory test evaluation failed to support the diagnosis of any primary inflammatory or genetic peripheral neuropathy and there was no evidence of any systemic fibrosing disorder including Systemic Sclerosis, lacking cutaneous fibrotic changes and cardiopulmonary abnormalities. The clinical course was progressive with sequential development of motor and sensory deficits of upper and lower extremities displaying proximal predominance. Histopathological study of tissues obtained during nerve release surgeries showed severe perineural fibrosis with marked accumulation of thick collagen bundles encroaching the peripheral nerves. There was no evidence of vasculitic, inflammatory, or vascular fibroproliferative lesions. We suggest that the clinical findings described here represent a previously undescribed fibrotic disorder affecting peripheral nerves, and we propose the descriptive term "Progressive Multifocal Fibrosing Neuropathy" to refer to this novel disorder. Despite the inherent limitations of this early description, we hope this is would contribute to the identification of additional cases.
format Online
Article
Text
id pubmed-8925190
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89251902022-03-23 Progressive multifocal fibrosing neuropathy: description of a novel disease Mendoza, Fabian A. Bagley, Jennifer Gochfeld, Michael Dalakas, Marinos C. Farber, John L. Jimenez, Sergio A. Acta Neuropathol Commun Case Report Entrapment peripheral neuropathies are clinically characterized by sensory impairment and motor deficits. They are usually caused by mechanical injuries, but they are also a frequent manifestation of metabolic diseases, toxic agent exposure, or systemic fibrotic disorders. Here we describe the clinical, radiological, and histopathological features of a novel progressive fibrotic disorder characterized by progressive multifocal fibrosing neuropathy. We identified two patients who presented with severe and progressive peripheral neuropathic symptoms sequentially affecting multiple sites. These patients presented with severe and progressive multifocal, sequentially additive peripheral neuropathic symptoms. Extensive nerve conduction and radiological studies showed the sequential development of multifocal motor and sensory peripheral neuropathy in the absence of any exposure to known infectious, inflammatory, or fibrotic triggers and the lack of family history of compression neuropathies. Extensive clinical and laboratory test evaluation failed to support the diagnosis of any primary inflammatory or genetic peripheral neuropathy and there was no evidence of any systemic fibrosing disorder including Systemic Sclerosis, lacking cutaneous fibrotic changes and cardiopulmonary abnormalities. The clinical course was progressive with sequential development of motor and sensory deficits of upper and lower extremities displaying proximal predominance. Histopathological study of tissues obtained during nerve release surgeries showed severe perineural fibrosis with marked accumulation of thick collagen bundles encroaching the peripheral nerves. There was no evidence of vasculitic, inflammatory, or vascular fibroproliferative lesions. We suggest that the clinical findings described here represent a previously undescribed fibrotic disorder affecting peripheral nerves, and we propose the descriptive term "Progressive Multifocal Fibrosing Neuropathy" to refer to this novel disorder. Despite the inherent limitations of this early description, we hope this is would contribute to the identification of additional cases. BioMed Central 2022-03-16 /pmc/articles/PMC8925190/ /pubmed/35296359 http://dx.doi.org/10.1186/s40478-022-01341-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Mendoza, Fabian A.
Bagley, Jennifer
Gochfeld, Michael
Dalakas, Marinos C.
Farber, John L.
Jimenez, Sergio A.
Progressive multifocal fibrosing neuropathy: description of a novel disease
title Progressive multifocal fibrosing neuropathy: description of a novel disease
title_full Progressive multifocal fibrosing neuropathy: description of a novel disease
title_fullStr Progressive multifocal fibrosing neuropathy: description of a novel disease
title_full_unstemmed Progressive multifocal fibrosing neuropathy: description of a novel disease
title_short Progressive multifocal fibrosing neuropathy: description of a novel disease
title_sort progressive multifocal fibrosing neuropathy: description of a novel disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925190/
https://www.ncbi.nlm.nih.gov/pubmed/35296359
http://dx.doi.org/10.1186/s40478-022-01341-8
work_keys_str_mv AT mendozafabiana progressivemultifocalfibrosingneuropathydescriptionofanoveldisease
AT bagleyjennifer progressivemultifocalfibrosingneuropathydescriptionofanoveldisease
AT gochfeldmichael progressivemultifocalfibrosingneuropathydescriptionofanoveldisease
AT dalakasmarinosc progressivemultifocalfibrosingneuropathydescriptionofanoveldisease
AT farberjohnl progressivemultifocalfibrosingneuropathydescriptionofanoveldisease
AT jimenezsergioa progressivemultifocalfibrosingneuropathydescriptionofanoveldisease